Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Myeloma2018 Session II

 

Genomics 2018 – What Have We Learned?

During session II of Myeloma2018, Yuan Xiao Zhu, PhD, presents on FAM46C, one of the most frequently mutated genes in multiple myeloma, and how it influences disease progression and treatment outcomes.

Presentations
FAM46C and Multiple Myeloma
Yuan Xiao Zhu, PhD
Mayo Clinic, Scottsdale, AZ
8 September, 2018

Yuan Xiao Zhu, PhD, from the Mayo Clinic, Scottsdale, AZ, discusses the role of FAM46C in multiple myeloma.

Previous session View all sessions Next session

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals